Project Grant HT94252410131
Award Date
7/1/24
Completion Date
6/30/26
Dollars Obligated
$313K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pittsburgh, PA 15260, USA
Similar Awards
The University of Pittsburgh was awarded a $1,572,933 federal Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. The grant, effective January 1, 2025 through December 31, 2028, supports advanced biomedical research aimed at "Targeting Lysosomal Pathways to Improve Host Immunity Post Coronaviral Infections." This research aligns with the program's objective to transform healthcare for military service members,...
The University of Pittsburgh has been awarded a $540,800 Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on microparticle delivery of chemokine muteins guiding chemokine receptor engineered Treg for tolerance induction after vascular composite allograft transplant. The 3-year award, which runs from September 15, 2024 to September 14, 2027, will support innovative scientific studies aimed at developing novel...
The University of Pittsburgh has been awarded a $747,131 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 10, 2024, supports the development of an Extracorporeal Perfusion System (EPS) for composite tissue regeneration. This research effort aims to advance innovative medical technologies to improve health outcomes for military service members and the broader public. The grant will fund a...
The University of Pittsburgh was awarded a $2,806,431.00 Project Grant on July 1, 2023 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to optimize small molecule therapeutics to treat focal segmental glomerulosclerosis. This basic, applied, and advanced biomedical research aims to transform health care by developing innovative and impactful medical solutions for Service Members and the American public. The University of Pittsburgh will...
The University of Pittsburgh received a $454,142.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "FERROPTOSIS AS A METABOLIC VULNERABILITY OF CYCLIN E-HIGH OVARIAN CANCER". This 2-year research project, with a performance period from May 2024 to May 2026, aims to investigate metabolic vulnerabilities in a specific type of ovarian cancer. The University of Pittsburgh is the primary...
This $1,264,474 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of Pittsburgh's research on "Molecular Insights into Immune Suppression in Kidney Cancer and Novel Therapeutic Opportunities". The grant, effective September 1, 2024 through August 31, 2028, will fund the university's investigations into improving understanding of immune system mechanisms involved in kidney cancer and...
The University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh, received a $724,997.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the project "RECOVERY OF TENDON INJURY BY TARGETING ITS ROOT CAUSE AND ENHANCING TENDON STEM CELLS." The grant period of performance is from July 1, 2023 to June 30, 2026. The project aims to conduct biomedical...
The University of Pittsburgh received a $4,902,315 project grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on June 1, 2025, with a completion date of May 31, 2029, is funding research to understand the effects of intracavitary conditioning in breast cancer metastatic to the pleura or the peritoneum. This research aims to transform healthcare for military service members, veterans, and the broader public by...
This $392,119 Project Grant was awarded on September 1, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Pittsburgh. The grant supports establishing statin/MBV-based therapies for enhancing optic nerve regeneration after traumatic optic neuropathy. The University of Pittsburgh, a major recipient of federal research grants, will leverage its academic expertise and research infrastructure to conduct this basic and...
The University of Pittsburgh - Of the Commonwealth System of Higher Education (University of Pittsburgh) was awarded a $1,246,455 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research to characterize a novel class of non-competitive androgen receptor antagonists from May 15, 2023 to May 14, 2026. The Military Medical Research and Development program aims to transform military and public health...